MAPK3 and cancer: Among monoclonal antibodies that have been investigated for their anti-cancer characteristics, the anti-CD40 antibody has been reported to cause apoptosis of diffuse large B-cell lymphoma cell lines with ERK1/2 activation through CD40 signaling [20].